Ardeparin
From Wikipedia, the free encyclopedia
 |
|
|
Ardeparin
|
|
| Systematic (IUPAC) name | |
| 6-[5-acetylamino-4,6-dihydroxy-2-(sulfooxymethyl)tetrahydropyran-3-yl]oxy-3-[5-(6-
carboxy-4,5-dihydroxy-3-sulfooxy-tetrahydropyran-2-yl)oxy-6-(hydroxymethyl)-3-sulfoamino- 4-sulfooxy-tetrahydropyran-2-yl]oxy-4-hydroxy-5-sulfooxy-tetrahydropyran-2-carboxylic acid |
|
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | ? |
| DrugBank | |
| Chemical data | |
| Formula | (C26H40N2O36S5)n |
| Mol. mass | 1134.93 |
| Pharmacokinetic data | |
| Bioavailability | 92% |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Ardeparin (brand name Normiflo) is an anticoagulant. It is used for prevention of deep vein thrombosis.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
